-
1
-
-
17644394616
-
Smoldering and polarized inflammation in the initiation and promotion of Malignant disease
-
PMID: 15766659
-
Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer cell. 2005; 7(3):211-7. doi:10.1016/j.ccr.2005.02.013 PMID: 15766659.
-
(2005)
Cancer Cell
, vol.7
, Issue.3
, pp. 211-217
-
-
Balkwill, F.1
Charles, K.A.2
Mantovani, A.3
-
2
-
-
0035901090
-
Inflammation and cancer: Back to virchow?
-
PMID: 11229684
-
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001; 357(9255):539-45. doi:10.1016/S0140-6736(00)04046-0 PMID: 11229684.
-
(2001)
Lancet
, vol.357
, Issue.9255
, pp. 539-545
-
-
Balkwill, F.1
Mantovani, A.2
-
3
-
-
0037180757
-
Inflammation and cancer
-
PMID: 12490959; PubMed Central PMCID: PMC2803035
-
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420(6917):860-7. doi:10.1038/nature01322 PMID: 12490959; PubMed Central PMCID: PMC2803035.
-
(2002)
Nature
, vol.420
, Issue.6917
, pp. 860-867
-
-
Coussens, L.M.1
Werb, Z.2
-
4
-
-
33745298519
-
Nuclear factor-kappaB in cancer development and progression
-
PMID: 16724054
-
Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006; 441 (7092):431-6. doi:10.1038/nature04870 PMID: 16724054.
-
(2006)
Nature
, vol.441
, Issue.7092
, pp. 431-436
-
-
Karin, M.1
-
5
-
-
47949096781
-
Cancer-related inflammation
-
PMID: 18650914
-
Mantovani A, Allavena P, Sica A., Balkwill F. Cancer-related inflammation. Nature. 2008; 454 (7203):436-44. doi:10.1038/nature07205 PMID: 18650914.
-
(2008)
Nature
, vol.454
, Issue.7203
, pp. 436-444
-
-
Mantovani, A.1
Allavena, P.2
Sica, A.3
Balkwill, F.4
-
6
-
-
31344466956
-
Chronic inflammation, immunosuppression and cancer: New insights and outlook
-
PMID: 16420981
-
Baniyash M. Chronic inflammation, immunosuppression and cancer: new insights and outlook. Seminars in cancer biology. 2006; 16(1):80-8. doi:10.1016/j.semcancer.2005.12.002 PMID: 16420981.
-
(2006)
Seminars in Cancer Biology
, vol.16
, Issue.1
, pp. 80-88
-
-
Baniyash, M.1
-
7
-
-
9644278053
-
Cytokines in cancer immunity and immunotherapy
-
PMID: 15546400
-
Smyth MJ, Cretney E, Kershaw M.H., Hayakawa Y. Cytokines in cancer immunity and immunotherapy. Immunological reviews. 2004; 202:275-93. doi:10.1111/j.0105-2896.2004.00199.x PMID: 15546400.
-
(2004)
Immunological Reviews
, vol.202
, pp. 275-293
-
-
Smyth, M.J.1
Cretney, E.2
Kershaw, M.H.3
Hayakawa, Y.4
-
8
-
-
0036694663
-
Regulation of cytokine signaling and inflammation
-
PMID: 12220554
-
Hanada T, Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine & growth factor reviews. 2002; 13(4-5):413-21. PMID: 12220554.
-
(2002)
Cytokine & Growth Factor Reviews
, vol.13
, Issue.4-5
, pp. 413-421
-
-
Hanada, T.1
Yoshimura, A.2
-
9
-
-
74949093638
-
Role of CSF-1 in progression of epithelial ovarian cancer
-
PMID: 19903070; PubMed Central PMCID: PMC2830097
-
Chambers SK. Role of CSF-1 in progression of epithelial ovarian cancer. Future oncology. 2009; 5 (9):1429-40. doi:10.2217/fon.09.103 PMID: 19903070; PubMed Central PMCID: PMC2830097.
-
(2009)
Future Oncology
, vol.5
, Issue.9
, pp. 1429-1440
-
-
Chambers, S.K.1
-
10
-
-
0035936797
-
The TNF and TNF receptor superfamilies: Integrating Mammalian biology
-
PMID: 11239407
-
Locksley RM, Killeen N, Lenardo MJ The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001; 104(4):487-501. PMID: 11239407.
-
(2001)
Cell.
, vol.104
, Issue.4
, pp. 487-501
-
-
Locksley, R.M.1
Killeen, N.2
Lenardo, M.J.3
-
11
-
-
0036375050
-
Interleukin-1 - A major pleiotropic cytokine in tumor-host interactions
-
PMID: 12147202
-
Apte RN, Voronov E. Interleukin-1 - a major pleiotropic cytokine in tumor-host interactions. Seminars in cancer biology. 2002; 12(4):277-90. PMID: 12147202.
-
(2002)
Seminars in Cancer Biology
, vol.12
, Issue.4
, pp. 277-290
-
-
Apte, R.N.1
Voronov, E.2
-
12
-
-
84855867670
-
Targeting the fas/FasL signaling pathway in cancer therapy
-
PMID: 22239437
-
Villa-Morales M., Fernandez-Piqueras J. Targeting the Fas/FasL signaling pathway in cancer therapy. Expert opinion on therapeutic targets. 2012; 16(1):85-101. doi:10.1517/14728222.2011.628937 PMID: 22239437.
-
(2012)
Expert Opinion on Therapeutic Targets
, vol.16
, Issue.1
, pp. 85-101
-
-
Villa-Morales, M.1
Fernandez-Piqueras, J.2
-
13
-
-
84855880717
-
Targeting the VEGF signaling pathway in cancertherapy
-
PMID: 22239434
-
Waldner MJ, Neurath MF Targeting the VEGF signaling pathway in cancertherapy. Expert opinion on therapeutic targets. 2012; 16(1):5-13. doi:10.1517/14728222.2011.641951 PMID: 22239434.
-
(2012)
Expert Opinion on Therapeutic Targets
, vol.16
, Issue.1
, pp. 5-13
-
-
Waldner, M.J.1
Neurath, M.F.2
-
14
-
-
84893867951
-
TGF-beta: Duality of function between tumor prevention and carcinogenesis
-
PMID: 24511106; PubMed Central PMCID: PMC3952197
-
Principe DR, Doll JA, Bauer J, Jung B., Munshi HG, Bartholin L, et al. TGF-beta: duality of function between tumor prevention and carcinogenesis. Journal of the National Cancer Institute. 2014; 106(2): djt369. doi:10.1093/jnci/djt369 PMID: 24511106; PubMed Central PMCID: PMC3952197.
-
(2014)
Journal of the National Cancer Institute
, vol.106
, Issue.2
-
-
Principe, D.R.1
Doll, J.A.2
Bauer, J.3
Jung, B.4
Munshi, H.G.5
Bartholin, L.6
-
15
-
-
34548131112
-
RegulatoryTcells expressing interleukin 10 develop from foxp3+ and foxp3- precursor cells in the absence of interleukin 10
-
PMID: 17694059
-
Maynard CL, Harrington LE, Janowski K.M., Oliver JR, Zindl CL, Rudensky AY, et al RegulatoryTcells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nature immunology. 2007; 8(9):931-41. doi:10.1038/ni1504 PMID: 17694059.
-
(2007)
Nature Immunology
, vol.8
, Issue.9
, pp. 931-941
-
-
Maynard, C.L.1
Harrington, L.E.2
Janowski, K.M.3
Oliver, J.R.4
Zindl, C.L.5
Rudensky, A.Y.6
-
16
-
-
0027204621
-
Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2)T cell clones and inhibits their antigen-specific proliferation and cytokine production
-
Baltimore, Md PMID: 8419468
-
Del Prete G., De Carli M, Almerigogna F, Giudizi M.G., Biagiotti R., Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2)T cell clones and inhibits their antigen-specific proliferation and cytokine production. Journal of immunology (Baltimore, Md: 1950). 1993; 150 (2):353-60. PMID: 8419468.
-
(1950)
Journal of Immunology
, vol.150
, Issue.2
, pp. 353-360
-
-
Del Prete, G.1
De Carli, M.2
Almerigogna, F.3
Giudizi, M.G.4
Biagiotti, R.5
Romagnani, S.6
-
17
-
-
0024408824
-
Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production byTh1 clones
-
PMID: 2531194; PubMed Central PMCID: PMC2189521
-
Fiorentino DF, Bond MW, Mosmann TR Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production byTh1 clones. The Journal of experimental medicine. 1989; 170 (6):2081-95. PMID: 2531194; PubMed Central PMCID: PMC2189521.
-
(1989)
The Journal of Experimental Medicine
, vol.170
, Issue.6
, pp. 2081-2095
-
-
Fiorentino, D.F.1
Bond, M.W.2
Mosmann, T.R.3
-
18
-
-
0027513170
-
Interleukin-10
-
PMID: 8386517
-
Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annual review of immunology. 1993; 11:165-90. doi:10.1146/annurev.iy.11.040193.001121 PMID: 8386517.
-
(1993)
Annual Review of Immunology
, vol.11
, pp. 165-190
-
-
Moore, K.W.1
O'Garra, A.2
De Waal Malefyt, R.3
Vieira, P.4
Mosmann, T.R.5
-
19
-
-
0037213614
-
The dual role of IL-10
-
Epub 2002/12/24. PMID: 12495723
-
Mocellin S, Panelli MC, Wang E, Nagorsen D., Marincola FM. The dual role of IL-10. Trends in immunology. 2003; 24(1):36-43. Epub 2002/12/24. PMID: 12495723.
-
(2003)
Trends in Immunology
, vol.24
, Issue.1
, pp. 36-43
-
-
Mocellin, S.1
Panelli, M.C.2
Wang, E.3
Nagorsen, D.4
Marincola, F.M.5
-
21
-
-
84885433913
-
Current status of interleukin-10 and regulatory T-cells in cancer
-
Epub 2013/10/01 PMID: 24076584
-
Dennis KL, Blatner NR, Gounari F, Khazaie K. Current status of interleukin-10 and regulatory T-cells in cancer. Current opinion in oncology. 2013; 25(6):637-45. Epub 2013/10/01. doi:10.1097/cco.0000000000000006 PMID: 24076584.
-
(2013)
Current Opinion in Oncology
, vol.25
, Issue.6
, pp. 637-645
-
-
Dennis, K.L.1
Blatner, N.R.2
Gounari, F.3
Khazaie, K.4
-
22
-
-
84860341228
-
Role of interleukin-10 in breast cancer
-
Epub 2011/11/08 PMID: 22057973
-
Hamidullah, Changkija B, Konwar R. Role of interleukin-10 in breast cancer. Breast cancer research and treatment. 2012; 133(1):11-21. Epub 2011/11/08. doi:10.1007/s10549-011-1855-x PMID: 22057973.
-
(2012)
Breast Cancer Research and Treatment
, vol.133
, Issue.1
, pp. 11-21
-
-
Hamidullah1
Changkija, B.2
Konwar, R.3
-
23
-
-
84856541896
-
Interleukin 10 in the tumor micro-environment: A target for anticancer immunotherapy
-
Epub 2011/12/06 PMID: 22139852
-
Sato T, Terai M, Tamura Y., Alexeev V, Mastrangelo MJ, Selvan SR Interleukin 10 in the tumor micro-environment: a target for anticancer immunotherapy. Immunologic research. 2011; 51(2-3):170-82. Epub 2011/12/06. doi:10.1007/s12026-011-8262-6 PMID: 22139852.
-
(2011)
Immunologic Research
, vol.51
, Issue.2-3
, pp. 170-182
-
-
Sato, T.1
Terai, M.2
Tamura, Y.3
Alexeev, V.4
Mastrangelo, M.J.5
Selvan, S.R.6
-
24
-
-
9644302458
-
Interleukin-10 in viral diseases and cancer: Exiting the labyrinth?
-
Epub 2004/11/18 PMID: 15546396
-
Vicari AP, Trinchieri G. Interleukin-10 in viral diseases and cancer: exiting the labyrinth? Immunological reviews. 2004; 202:223-36. Epub 2004/11/18. doi:10.1111/j.0105-2896.2004.00216.x PMID: 15546396.
-
(2004)
Immunological Reviews
, vol.202
, pp. 223-236
-
-
Vicari, A.P.1
Trinchieri, G.2
-
25
-
-
0029875958
-
Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer
-
PMID: 8606382
-
Kundu N, Beaty TL, Jackson M.J., Fulton AM. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. Journal of the National Cancer Institute. 1996; 88(8):536-41. PMID: 8606382.
-
(1996)
Journal of the National Cancer Institute
, vol.88
, Issue.8
, pp. 536-541
-
-
Kundu, N.1
Beaty, T.L.2
Jackson, M.J.3
Fulton, A.M.4
-
26
-
-
0032964570
-
Interleukin-10 levels are often elevated in serum of adults with hodgkin's disease and are associated with inferior failure-free survival
-
Epub 1999/06/17. PMID: 10370786
-
Sarris AH, Kliche KO, Pethambaram P, Preti A., Tucker S, Jackow C, et al Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 1999; 10(4):433-40. Epub 1999/06/17. PMID: 10370786.
-
(1999)
Annals of Oncology: Official Journal of the European Society for Medical Oncology / ESMO
, vol.10
, Issue.4
, pp. 433-440
-
-
Sarris, A.H.1
Kliche, K.O.2
Pethambaram, P.3
Preti, A.4
Tucker, S.5
Jackow, C.6
-
27
-
-
0033635585
-
Biological markers may add to prediction of outcome achieved by the international prognostic score in hodgkin's disease
-
Epub 2001/01/06. PMID: 11142480
-
Axdorph U, Sjoberg J, Grimfors G., Landgren O, Porwit-MacDonald A, Bjorkholm M. Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2000; 11 (11):1405-11. Epub 2001/01/06. PMID: 11142480.
-
(2000)
Annals of Oncology: Official Journal of the European Society for Medical Oncology / ESMO
, vol.11
, Issue.11
, pp. 1405-1411
-
-
Axdorph, U.1
Sjoberg, J.2
Grimfors, G.3
Landgren, O.4
Porwit-MacDonald, A.5
Bjorkholm, M.6
-
28
-
-
0038281412
-
High pretreatment interleukin-10 is an independent predictor of poor failure-free survival in patients with hodgkin's lymphoma
-
Epub 2003/06/14. PMID: 12803112
-
Salgami EV, Efstathiou SP, Vlachakis V, Sekara E.V., Syrigos KN, Roussou PP. High pretreatment interleukin-10 is an independent predictor of poor failure-free survival in patients with Hodgkin's lymphoma. Haematologia. 2002; 32(4):377-87. Epub 2003/06/14. PMID: 12803112.
-
(2002)
Haematologia
, vol.32
, Issue.4
, pp. 377-387
-
-
Salgami, E.V.1
Efstathiou, S.P.2
Vlachakis, V.3
Sekara, E.V.4
Syrigos, K.N.5
Roussou, P.P.6
-
29
-
-
4544339987
-
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with hodgkin's disease treated with radiotherapy
-
Epub 2004/09/17 PMID: 15370254
-
Visco C, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S., Bonfante V, et al. Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy. Leukemia & lymphoma. 2004; 45(10):2085-92. Epub 2004/09/17. doi:10.1080/10428190410001712234 PMID: 15370254.
-
(2004)
Leukemia & Lymphoma
, vol.45
, Issue.10
, pp. 2085-2092
-
-
Visco, C.1
Vassilakopoulos, T.P.2
Kliche, K.O.3
Nadali, G.4
Viviani, S.5
Bonfante, V.6
-
30
-
-
3042511800
-
Clinical significance of thrombospon-din-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma
-
PMID: MEDLINE:12963968
-
Kaio E, Tanaka S, Oka S., Hiyama T, Kitadai Y, Haruma K., et al. Clinical significance of thrombospon-din-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma. International journal of oncology. 2003; 23(4):901-11. PMID: MEDLINE:12963968.
-
(2003)
International Journal of Oncology
, vol.23
, Issue.4
, pp. 901-911
-
-
Kaio, E.1
Tanaka, S.2
Oka, S.3
Hiyama, T.4
Kitadai, Y.5
Haruma, K.6
-
31
-
-
0038666325
-
Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer
-
PMID: MEDLINE:12738735
-
Soria J-C, Moon C, Kemp B.L., Liu DD, Feng L, Tang X, et al Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2003; 9(5):1785-91. PMID: MEDLINE:12738735.
-
(2003)
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
, vol.9
, Issue.5
, pp. 1785-1791
-
-
Soria, J.-C.1
Moon, C.2
Kemp, B.L.3
Liu, D.D.4
Feng, L.5
Tang, X.6
-
32
-
-
76849084918
-
Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma
-
PMID: MEDLINE:20037839
-
Toiyama Y, Miki C, Inoue Y., Minobe S, Urano H, Kusunoki M. Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma. Surgery today. 2010; 40(1):46-53. doi:10.1007/s00595-009-4016-7 PMID: MEDLINE:20037839.
-
(2010)
Surgery Today
, vol.40
, Issue.1
, pp. 46-53
-
-
Toiyama, Y.1
Miki, C.2
Inoue, Y.3
Minobe, S.4
Urano, H.5
Kusunoki, M.6
-
33
-
-
67349098558
-
Human interleukin 10 receptor 1/IgG1-fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential
-
PMID: 19142637
-
Terai M, Tamura Y, Alexeev V., Ohtsuka E, Berd D, Mastrangelo M.J., et al. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential. Cancer immunology, immunotherapy: CII. 2009; 58(8):1307-17. doi:10.1007/s00262-008-0644-9 PMID: 19142637.
-
(2009)
Cancer Immunology, Immunotherapy: CII
, vol.58
, Issue.8
, pp. 1307-1317
-
-
Terai, M.1
Tamura, Y.2
Alexeev, V.3
Ohtsuka, E.4
Berd, D.5
Mastrangelo, M.J.6
-
34
-
-
0029070119
-
A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses
-
Baltimore, Md 1995 PMID: 7730651
-
Chernoff AE, Granowitz EV, Shapiro L, Vannier E., Lonnemann G, Angel JB, et al A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. Journal of immunology (Baltimore, Md: 1950). 1995; 154(10):5492-9. PMID: 7730651.
-
(1950)
Journal of Immunology
, vol.154
, Issue.10
, pp. 5492-5499
-
-
Chernoff, A.E.1
Granowitz, E.V.2
Shapiro, L.3
Vannier, E.4
Lonnemann, G.5
Angel, J.B.6
-
35
-
-
0037136303
-
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody
-
PMID: 12186845; PubMed Central PMCID: PMC2196048
-
Vicari AP, Chiodoni C, Vaure C., Ait-Yahia S, Dercamp C, Matsos F., et al. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. The Journal of experimental medicine. 2002; 196(4):541-9. PMID: 12186845; PubMed Central PMCID: PMC2196048.
-
(2002)
The Journal of Experimental Medicine
, vol.196
, Issue.4
, pp. 541-549
-
-
Vicari, A.P.1
Chiodoni, C.2
Vaure, C.3
Ait-Yahia, S.4
Dercamp, C.5
Matsos, F.6
-
36
-
-
84879189270
-
Pegylated IL-10 induces cancer immunity: The surprising role of IL-10 as a potent inducer of IFN-gamma-mediated CD8(+) T cell cytotoxicity
-
Epub 2013/05/15 PMID: 23666891
-
Mumm JB, Oft M. Pegylated IL-10 induces cancer immunity: the surprising role of IL-10 as a potent inducer of IFN-gamma-mediated CD8(+) T cell cytotoxicity. BioEssays: news and reviews in molecular, cellular and developmental biology. 2013; 35(7):623-31. Epub 2013/05/15. doi:10.1002/bies. 201300004 PMID: 23666891.
-
(2013)
BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology
, vol.35
, Issue.7
, pp. 623-631
-
-
Mumm, J.B.1
Oft, M.2
-
37
-
-
30944450549
-
Analysing and presenting results
-
Higgins JPT, Green S, ed 425 Chichester, UK: John Wiley & Sons ncer Res.
-
Deeks JJH. AD J. Analysing and presenting results. In: Higgins JPT, Green S, ed Cochrane Handbook for Systematic Reviews of Interventions 425 Chichester, UK: John Wiley & Sons ncer Res. 2006; 15: p. 6341-7.
-
(2006)
Cochrane Handbook for Systematic Reviews of Interventions
, vol.15
, pp. 6341-6347
-
-
Deeks, J.J.H.1
Ad, J.2
-
38
-
-
0027434991
-
Serum interleukin-10 in non-hodgkin's lymphoma: A prognostic factor
-
Epub 1993/10/01. PMID: 8400266
-
Blay JY, Burdin N, Rousset F., Lenoir G, Biron P, Philip T., et al. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood. 1993; 82(7):2169-74. Epub 1993/10/01. PMID: 8400266.
-
(1993)
Blood
, vol.82
, Issue.7
, pp. 2169-2174
-
-
Blay, J.Y.1
Burdin, N.2
Rousset, F.3
Lenoir, G.4
Biron, P.5
Philip, T.6
-
39
-
-
0034034187
-
Poor clinical outcome of patients with hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for hodgkin's disease
-
Epub 2000/05/10. PMID: 10803931
-
Bohlen H, Kessler M, Sextro M., Diehl V, Tesch H. Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease. Annals of hematology. 2000; 79(3):110-3. Epub 2000/05/10. PMID: 10803931.
-
(2000)
Annals of Hematology
, vol.79
, Issue.3
, pp. 110-113
-
-
Bohlen, H.1
Kessler, M.2
Sextro, M.3
Diehl, V.4
Tesch, H.5
-
40
-
-
84864651241
-
A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma
-
PMID: MEDLINE:22180222
-
Chan SL, Mo FKF, Wong CSC, Chan CML, Leung LKS, Hui EP, et al A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma. Cancer. 2012; 118(16):3984-92. doi:10.1002/cncr.26726 PMID: MEDLINE:22180222.
-
(2012)
Cancer
, vol.118
, Issue.16
, pp. 3984-3992
-
-
Chan, S.L.1
Mo, F.K.F.2
Wong, C.S.C.3
Chan, C.M.L.4
Leung, L.K.S.5
Hui, E.P.6
-
41
-
-
0028933071
-
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: Lack of correlation with prognosis
-
PMID: MEDLINE:7537119
-
Cortes JE, Talpaz M, Cabanillas F., Seymour JF, Kurzrock R. Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis. Blood. 1995; 85(9):2516-20. PMID: MEDLINE:7537119.
-
(1995)
Blood
, vol.85
, Issue.9
, pp. 2516-2520
-
-
Cortes, J.E.1
Talpaz, M.2
Cabanillas, F.3
Seymour, J.F.4
Kurzrock, R.5
-
42
-
-
0033570973
-
Serum interleukin-10 levels in patients with advanced gastrointestinal Malignancies
-
PMID: MEDLINE: 10570416
-
De Vita F., Orditura M, Galizia G., Romano C, Infusino S, Auriemma A., et al. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer. 1999; 86(10):1936-43. doi: 10.1002/(sici)1097-0142(19991115)86:10<1936::aid-cncr9>3.0.co;2-9 PMID: MEDLINE: 10570416.
-
(1999)
Cancer
, vol.86
, Issue.10
, pp. 1936-1943
-
-
De Vita, F.1
Orditura, M.2
Galizia, G.3
Romano, C.4
Infusino, S.5
Auriemma, A.6
-
43
-
-
0033994349
-
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients
-
PMID: MEDLINE:10669676
-
De Vita F., Orditura M, Galizia G., Romano C, Roscigno A, Lieto E., et al. Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients. Chest. 2000; 117(2):365-73. doi:10.1378/chest.117.2.365 PMID: MEDLINE:10669676.
-
(2000)
Chest
, vol.117
, Issue.2
, pp. 365-373
-
-
De Vita, F.1
Orditura, M.2
Galizia, G.3
Romano, C.4
Roscigno, A.5
Lieto, E.6
-
44
-
-
10044261013
-
Cytokines in pancreatic carcinoma: Correlation with phenotypic characteristics and prognosis
-
PMID: MEDLINE:15526319
-
Ebrahimi B, Tucker SL, Li D, Abbruzzese J.L., Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer. 2004; 101(12):2727-36. doi:10.1002/cncr. 20672 PMID: MEDLINE:15526319.
-
(2004)
Cancer
, vol.101
, Issue.12
, pp. 2727-2736
-
-
Ebrahimi, B.1
Tucker, S.L.2
Li, D.3
Abbruzzese, J.L.4
Kurzrock, R.5
-
45
-
-
33646849272
-
The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival
-
PMID: 20927906
-
Evans C, Morrison I, Heriot AG, Bartlett J.B., Finlayson C., Dalgleish AG, et al. The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival. British journal of cancer. 2006; 94(10):1412-9. doi:10.1038/sj.bjc.6603104 PMID: 20927906.
-
(2006)
British Journal of Cancer
, vol.94
, Issue.10
, pp. 1412-1419
-
-
Evans, C.1
Morrison, I.2
Heriot, A.G.3
Bartlett, J.B.4
Finlayson, C.5
Dalgleish, A.G.6
-
46
-
-
0035160749
-
Interleukin-6and interleukin-10 levels in chronic lymphocytic leukemia: Correlation with phenotypic characteristics and outcome
-
PMID: MEDLINE:11133769
-
Fayad L, Keating MJ, Reuben J.M., O'Brien S, Lee BN, Lerner S, et al Interleukin-6and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood. 2001; 97(1):256-63. doi:10.1182/blood.V97.1.256 PMID: MEDLINE:11133769.
-
(2001)
Blood
, vol.97
, Issue.1
, pp. 256-263
-
-
Fayad, L.1
Keating, M.J.2
Reuben, J.M.3
O'Brien, S.4
Lee, B.N.5
Lerner, S.6
-
47
-
-
84857187863
-
Serum IL10, IL12 and circulating CD4+CD25high T regulatory cells in relation to long-term clinical outcome in head and neck squamous cell carcinoma patients
-
PMID: MEDLINE:22075762
-
Green VL, Irune E, Prasai A., Alhamarneh O, Greenman J, Stafford ND Serum IL10, IL12 and circulating CD4+CD25high T regulatory cells in relation to long-term clinical outcome in head and neck squamous cell carcinoma patients. International journal of oncology. 2012; 40(3):833-9. doi:10.3892/ijo.2011.1259 PMID: MEDLINE:22075762.
-
(2012)
International Journal of Oncology
, vol.40
, Issue.3
, pp. 833-839
-
-
Green, V.L.1
Irune, E.2
Prasai, A.3
Alhamarneh, O.4
Greenman, J.5
Stafford, N.D.6
-
48
-
-
0346895107
-
Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma
-
Hattori E, Okumoto K, Adachi T, Takeda T., Ito J-i, Sugahara K, et al Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma. Hepatology Research. 2003; 27(4):309.
-
(2003)
Hepatology Research
, vol.27
, Issue.4
, pp. 309
-
-
Hattori, E.1
Okumoto, K.2
Adachi, T.3
Takeda, T.4
Ito, J.-I.5
Sugahara, K.6
-
49
-
-
77952781844
-
Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-cell lymphoma in different risk groups defined by the international prognostic index
-
PMID: MEDLINE:20191326
-
Lech-Maranda E., Bienvenu J, Broussais-Guillaumot F, Warzocha K., Michallet A-S, Robak T, et al Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index. Archivum immunologiaeettherapiaeexperimentalis. 2010; 58(2):131-41. doi:10.1007/s00005-010-0066-1 PMID: MEDLINE:20191326.
-
(2010)
Archivum Immunologiaeettherapiaeexperimentalis
, vol.58
, Issue.2
, pp. 131-141
-
-
Lech-Maranda, E.1
Bienvenu, J.2
Broussais-Guillaumot, F.3
Warzocha, K.4
Michallet, A.-S.5
Robak, T.6
-
50
-
-
84872103461
-
Serum tumor necrosis factor-alpha and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status
-
PMID: MEDLINE:22945689
-
Lech-Maranda E., Grzybowska-Izydorczyk O, Wyka K., Mlynarski W, Borowiec M, Antosik K., et al. Serum tumor necrosis factor-alpha and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status. Archivum immunologiae ettherapiae experimentalis. 2012; 60(6):477-86. doi:10.1007/s00005-012-0197-7 PMID: MEDLINE:22945689.
-
(2012)
Archivum Immunologiae Ettherapiae Experimentalis
, vol.60
, Issue.6
, pp. 477-486
-
-
Lech-Maranda, E.1
Grzybowska-Izydorczyk, O.2
Wyka, K.3
Mlynarski, W.4
Borowiec, M.5
Antosik, K.6
-
51
-
-
43849092649
-
Correlation of serum IL-6, IL-8and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma
-
PMID: MEDLINE:18479302
-
Nacinovic-Duletic A., Stifter S, Dvornik S., Skunca Z, Jonjic N. Correlation of serum IL-6, IL-8and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma. International journal of laboratory hematology. 2008; 30(3):230-9. doi:10.1111/j.1751-553X.2007. 00951.x PMID: MEDLINE:18479302.
-
(2008)
International Journal of Laboratory Hematology
, vol.30
, Issue.3
, pp. 230-239
-
-
Nacinovic-Duletic, A.1
Stifter, S.2
Dvornik, S.3
Skunca, Z.4
Jonjic, N.5
-
52
-
-
0035029602
-
Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma
-
PMID: MEDLINE:11338880
-
Nemunaitis J, Fong T, Shabe P., Martineau D, Ando D. Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma. Cancer investigation. 2001; 19 (3):239-47. doi:10.1081/cnv-100102550 PMID: MEDLINE:11338880.
-
(2001)
Cancer Investigation
, vol.19
, Issue.3
, pp. 239-247
-
-
Nemunaitis, J.1
Fong, T.2
Shabe, P.3
Martineau, D.4
Ando, D.5
-
53
-
-
75149137817
-
Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer
-
PMID: MEDLINE:20044609
-
Szaflarska A, Szczepanik A, Siedlar M, Czupryna A., Sierzega M, Popiela T, et al Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer. Anticancer research. 2009; 29(12):5005-12. PMID: MEDLINE:20044609.
-
(2009)
Anticancer Research
, vol.29
, Issue.12
, pp. 5005-5012
-
-
Szaflarska, A.1
Szczepanik, A.2
Siedlar, M.3
Czupryna, A.4
Sierzega, M.5
Popiela, T.6
-
54
-
-
0035074841
-
Serum interleukin-10 levels are an independent prognostic factor for patients with hodgkin's lymphoma
-
PMID: MEDLINE:11255274
-
Vassilakopoulos TP, Nadali G, Angelopoulou M.K., Siakantaris MP, Dimopoulou MN, Kontopidou FN, et al Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma. Haematologica. 2001; 86(3):274-81. PMID: MEDLINE:11255274.
-
(2001)
Haematologica
, vol.86
, Issue.3
, pp. 274-281
-
-
Vassilakopoulos, T.P.1
Nadali, G.2
Angelopoulou, M.K.3
Siakantaris, M.P.4
Dimopoulou, M.N.5
Kontopidou, F.N.6
-
55
-
-
0034059443
-
Elevated pretreatment serum levels of il-10 are associated with a poor prognosis in hodgkin's disease, the milan cancer institute experience
-
PMID: MEDLINE:10713662
-
Viviani S, Notti P, Bonfante V., Verderio P, Valagussa P, Bonadonna G. Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience. Medical oncology (Northwood, London, England). 2000; 17(1):59-63. doi:10.1007/bf02826218 PMID: MEDLINE:10713662.
-
(2000)
Medical Oncology (Northwood, London, England)
, vol.17
, Issue.1
, pp. 59-63
-
-
Viviani, S.1
Notti, P.2
Bonfante, V.3
Verderio, P.4
Valagussa, P.5
Bonadonna, G.6
-
56
-
-
0034028927
-
Serum interleukin-10butnotinterleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma
-
Epub 2000/04/05. PMID: 10749617; PubMed Central PMCID: PMCPmc1421032
-
Chau GY, Wu CW, Lui W.Y., Chang TJ, Kao HL, Wu LH, et al Serum interleukin-10butnotinterleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Annals of surgery. 2000; 231(4):552-8. Epub 2000/04/05. PMID: 10749617; PubMed Central PMCID: PMCPmc1421032.
-
(2000)
Annals of Surgery
, vol.231
, Issue.4
, pp. 552-558
-
-
Chau, G.Y.1
Wu, C.W.2
Lui, W.Y.3
Chang, T.J.4
Kao, H.L.5
Wu, L.H.6
-
57
-
-
0036176551
-
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery
-
PMID: MEDLINE:11846459
-
Galizia G, Orditura M, Romano C, Lieto E., Castellano P, Pelosio L, et al Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clinical immunology (Orlando, Fla). 2002; 102(2):169-78. doi:10.1006/clim.2001.5163 PMID: MEDLINE:11846459.
-
(2002)
Clinical Immunology (Orlando, Fla)
, vol.102
, Issue.2
, pp. 169-178
-
-
Galizia, G.1
Orditura, M.2
Romano, C.3
Lieto, E.4
Castellano, P.5
Pelosio, L.6
-
58
-
-
18444404007
-
Circulating levels of interleu-kin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: Relationship with radicality and outcome
-
Epub 2002/05/30 PMID: 12034030
-
Galizia G, Lieto E, De Vita F, Romano C, Orditura M., Castellano P, et al. Circulating levels of interleu-kin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research. 2002; 22(4):473-82. Epub 2002/05/30. doi:10.1089/10799900252952262 PMID: 12034030.
-
(2002)
Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research
, vol.22
, Issue.4
, pp. 473-482
-
-
Galizia, G.1
Lieto, E.2
De Vita, F.3
Romano, C.4
Orditura, M.5
Castellano, P.6
|